BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7594566)

  • 1. A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex.
    Fodor WL; Rollins SA; Guilmette ER; Setter E; Squinto SP
    J Immunol; 1995 Nov; 155(9):4135-8. PubMed ID: 7594566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T; Zhou L; Hilliard B; Molina H; Song WC
    Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.
    Bao L; Haas M; Minto AW; Quigg RJ
    Lab Invest; 2007 Apr; 87(4):357-64. PubMed ID: 17259999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
    Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
    Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of different combinations of human MCP, DAF, and CD59 on complement-dependent cytolysis in NIH 3T3 cells.
    Yang X; Deng J; Jiang Z; Liao DJ; Jiang H
    Exp Clin Transplant; 2012 Feb; 10(1):49-54. PubMed ID: 22309420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
    Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
    Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion.
    Shiraishi M; Nagahama M; Nozato E; Oshiro T; Taira K; Muto Y
    Transplant Proc; 2000 Aug; 32(5):1116-7. PubMed ID: 10936387
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of the paroxysmal nocturnal hemoglobinuria phenotype in normal human erythrocytes: effects of 2-aminoethylisothiouronium bromide on membrane proteins that regulate complement.
    Ezzell JL; Wilcox LA; Bernshaw NJ; Parker CJ
    Blood; 1991 Jun; 77(12):2764-73. PubMed ID: 1710519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59.
    Qian YM; Qin X; Miwa T; Sun X; Halperin JA; Song WC
    J Immunol; 2000 Sep; 165(5):2528-34. PubMed ID: 10946279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
    Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
    J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU).
    Jha P; Sohn JH; Xu Q; Wang Y; Kaplan HJ; Bora PS; Bora NS
    J Immunol; 2006 Jun; 176(12):7221-31. PubMed ID: 16751365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The change of membrane complement regulatory protein in chorion of early pregnancy.
    Nishikori K; Noma J; Hirakawa S; Amano T; Kudo T
    Clin Immunol Immunopathol; 1993 Nov; 69(2):167-74. PubMed ID: 7691457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
    Yamada K; Miwa T; Liu J; Nangaku M; Song WC
    J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
    Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
    Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
    Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
    J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG; Mold C; Atkinson JP; Medof ME
    J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.